Subject(s)

Humans , Hepatorenal Syndrome/drug therapy , Albumins/administration & dosage , Terlipressin/administration & dosage , Liver Cirrhosis/complications , United States , Vasoconstrictor Agents/therapeutic use , Canada , Reproducibility of Results , Treatment Outcome , Evidence-Based Medicine , Drug Therapy, Combination , Kidney/drug effects

Subject(s)

Humans , Male , Female , Adolescent , Adult , Middle Aged , Aged , Hepatorenal Syndrome/mortality , Hepatorenal Syndrome/drug therapy , Octreotide/administration & dosage , Albumins/administration & dosage , Terlipressin/administration & dosage , Midodrine/administration & dosage , Hepatorenal Syndrome/diagnosis , Drug Administration Schedule , Survival Analysis , Reproducibility of Results , Follow-Up Studies , Treatment Outcome , Evidence-Based Medicine , Drug Therapy, Combination , Liver Function Tests